Search

Your search keyword '"Zuo YY"' showing total 113 results

Search Constraints

Start Over You searched for: Author "Zuo YY" Remove constraint Author: "Zuo YY"
113 results on '"Zuo YY"'

Search Results

51. Oxygen content determines the bio-reactivity and toxicity profiles of carbon black particles.

52. Tuning protein assembly pathways through superfast amyloid-like aggregation.

54. Knockout of a P-glycoprotein gene increases susceptibility to abamectin and emamectin benzoate in Spodoptera exigua.

55. 3D printing nano conductive multi-walled carbon nanotube scaffolds for nerve regeneration.

56. Prediction of acute inhalation toxicity using in vitro lung surfactant inhibition.

57. Mesoporous carbon nanomaterials induced pulmonary surfactant inhibition, cytotoxicity, inflammation and lung fibrosis.

58. Accuracy of Axisymmetric Drop Shape Analysis in Determining Surface and Interfacial Tensions.

59. Impact of ventilation-induced lung injury on the structure and function of lamellar bodies.

60. Perturbation of the pulmonary surfactant monolayer by single-walled carbon nanotubes: a molecular dynamics study.

61. Unveiling the Molecular Structure of Pulmonary Surfactant Corona on Nanoparticles.

62. Xylem Surfactants Introduce a New Element to the Cohesion-Tension Theory.

63. Factorial Design Based Multivariate Modeling and Optimization of Tunable Bioresponsive Arginine Grafted Poly(cystaminebis(acrylamide)-diaminohexane) Polymeric Matrix Based Nanocarriers.

64. The effect of diet-induced serum hypercholesterolemia on the surfactant system and the development of lung injury.

65. Phase Transitions in Dipalmitoylphosphatidylcholine Monolayers.

66. The effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury.

67. Automated Droplet Manipulation Using Closed-Loop Axisymmetric Drop Shape Analysis.

68. Differential susceptibility of transgenic mice expressing human surfactant protein B genetic variants to Pseudomonas aeruginosa induced pneumonia.

69. Effects of graphene oxide nanosheets on the ultrastructure and biophysical properties of the pulmonary surfactant film.

70. Time-averaged serum potassium levels and its fluctuation associate with 5-year survival of peritoneal dialysis patients: two-center based study.

71. Crucial Role of Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-inflammatory Responses in Cells and Animals.

72. Long-chain Acylcarnitines Reduce Lung Function by Inhibiting Pulmonary Surfactant.

73. Biophysical influence of airborne carbon nanomaterials on natural pulmonary surfactant.

74. Quantitatively predicting bacterial adhesion using surface free energy determined with a spectrophotometric method.

75. Antimicrobial and biophysical properties of surfactant supplemented with an antimicrobial peptide for treatment of bacterial pneumonia.

76. Shape affects the interactions of nanoparticles with pulmonary surfactant.

77. Surface free energy activated high-throughput cell sorting.

78. Rapid spectrophotometric method for determining surface free energy of microalgal cells.

79. Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunction.

80. Promote potential applications of nanoparticles as respiratory drug carrier: insights from molecular dynamics simulations.

81. Impact of substratum surface on microbial community structure and treatment performance in biological aerated filters.

82. Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona.

83. [Measurement of peak velocity variation of common carotid artery with bedside ultrasound to estimate preload in surgery ICU].

84. Influence of cell properties on rheological characterization of microalgae suspensions.

85. [Relationship between early serum albumin variation and prognosis in patients with severe acute pancreatitis treated in ICU].

86. Dietary calcium decreases plasma cholesterol level only in female but not in male hamster fed a high cholesterol diet.

87. Self-assembled amyloid-like oligomeric-cohesin Scaffoldin for augmented protein display on the saccharomyces cerevisiae cell surface.

88. A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactant.

89. Quantification of high-power ultrasound induced damage on potato starch granules using light microscopy.

90. Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.

91. The association of mean glucose level and glucose variability with intensive care unit mortality in patients with severe acute pancreatitis.

92. Biophysical interaction between corticosteroids and natural surfactant preparation: implications for pulmonary drug delivery using surfactant a a carrier.

93. [Short-term intensive glucose control in patients with severe acute pancreatitis].

94. [Effects of ketamine on proliferation and apoptosis of pheochromocytoma cell].

95. Atomic force microscopy analysis of rat pulmonary surfactant films.

96. Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant.

97. On the low surface tension of lung surfactant.

98. Comparative study of clinical pulmonary surfactants using atomic force microscopy.

99. Recent advances in alveolar biology: some new looks at the alveolar interface.

100. Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.

Catalog

Books, media, physical & digital resources